Eliot Williams, MD, PhD
Basic profileUniversity of Wisconsin Carbone Cancer Center
Eliot Williams is a Hematology physician affiliated with University of Wisconsin Carbone Cancer Center. OpenAlex indexes 48 publications with 1,835 citations (h-index 20); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Sponsor: Carelon Research
- Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Sponsor: Carelon Research
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
37.7%Antimetabolite31.6%Hydroxyurea100%Part D≥16 patientsKinase inhibitor6%Sirolimus100%Part D<11 patientsBlood & clotting
24.7%Thrombopoietin Receptor Agonist10.2%Promacta100%Part D<11 patientsFactor Xa inhibitor8.8%Eliquis100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
20.9%Corticosteroid20.9%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1985–1987 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2024 - Hepatic and Renal Histotripsy in an Anticoagulated Porcine Model
Journal of Vascular and Interventional Radiology
2022 - Emergent Reversal of Antithrombotics and Treatment of Life-Threatening Bleeding from Coagulopathies: A Clinical Review
Journal of Emergency Medicine
2022 - Unexplained Hematocrit Increase after Therapeutic Phlebotomy in a Patient with Marked Erythrocytosis
Case Reports in Hematology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Natalie Callander, MD
University of Wisconsin Carbone Cancer Center
Glenn Liu, MD
University of Wisconsin Carbone Cancer Center
Hongtao Liu
University of Wisconsin Carbone Cancer Center
Susan Payne, MD
University of Wisconsin Carbone Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”